Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Opens Biomarker Discovery Center


Ciphergen Biosystems has opened its first biomarker discovery center in Palo Alto, Calif., dedicated to proteomics research and protein biomarker discovery including differential protein expression, protein characterization, assay development and validation, and protein interaction studies.

The studies will use Ciphergen’s ProteinChip System and Arrays.

The BDC hopes to forge corporate and customer relationships to discover, characterize, and validate novel protein biomarkers from biological samples provided by Ciphergen’s collaborators.

Protein biomarkers can be used to identify disease prior to the appearance of physical symptoms, as well as identify new disease pathways and drug targets, the company said.

Filed under

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.